ITT for projects 10075464, 10074571, 10074091
The value below is a framework or dynamic market ceiling: the maximum
that could be spent across all call-offs, not the value of a single contract.
Aggregate figures on this site exclude these to avoid double counting.
key details
| Value | £2,790 |
|---|---|
| Status | complete |
| Category (CPV) | 79421100 |
| Deadline | 11 May 2023 |
| Contract start | 1 Jun 2023 |
| Contract end | 30 Nov 2023 |
| Procedure | selective |
| SME suitable | Yes |
| OCID | ocds-b5fd17-d33111b0-899f-4d56-b477-31adbbb0220a |
Award
| Supplier | Value | Date | Status |
|---|---|---|---|
| Carroll Pharma Consulting | £2,790 | 23 May 2023 | active |
description
ITT for projects 10075464, 10074571, 10074091
notice history
1 notice published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 14 Jun 2023 | Award (award) | · | ff35b38f-ad99-404b-afa7-7e8d615dbf3f-653682 |
more from UK RESEARCH & INNOVATION
- ITT for Project 10186644 · £7,420 · 3 Jul 2026
- ITT for Project 10183728 · £5,350 · 3 Jul 2026
- ITT for Project 10186439 · £3,050 · 3 Jul 2026
- ITT for Project 10183200 · £4,830 · 3 Jul 2026
- ITT for Project 10186870 · £4,830 · 3 Jul 2026
- ITT for Project 10187298 · £4,540 · 3 Jul 2026
- ITT for Project 10186332 · £7,900 · 3 Jul 2026
- ITT for Project 10183002 · £5,813 · 3 Jul 2026
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- ITT for Project 10186644 · UK RESEARCH & INNOVATION · £7,420
- ITT for Project 10186439 · UK RESEARCH & INNOVATION · £3,050
- ITT for Project 10183200 · UK RESEARCH & INNOVATION · £4,830
- ITT for Project 10186870 · UK RESEARCH & INNOVATION · £4,830
- ITT for Project 10187298 · UK RESEARCH & INNOVATION · £4,540
- ITT for Project 10186332 · UK RESEARCH & INNOVATION · £7,900
- ITT for Project 10183002 · UK RESEARCH & INNOVATION · £5,813
- ITT for Project 10184816 · UK RESEARCH & INNOVATION · £5,400
source
Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.